CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenues	$ 1,136,147	$ 653,445
Expenses:
Medical services expense	972,827	566,208
Other medical expenses	86,024	44,773
General and administrative (including noncash stock-based compensation expense of $13,672 and $3,970, respectively)	66,846	39,834
Depreciation and amortization	4,189	3,373
Total expenses	1,129,886	654,188
Income (loss) from operations	6,261	(743)
Other income (expense):
Other income (expense), net	9,472	2,269
Interest expense	(1,533)	(871)
Income (loss) before income taxes	14,200	655
Income tax benefit (expense)	1,759	71
Income (loss) from continuing operations	15,959	726
Total discontinued operations	0	429
Discontinued operations:
Net income (loss)	15,959	1,155
Noncontrolling interests' share in (earnings) loss	63	75
Net income (loss) attributable to common shares	$ 16,022	$ 1,230
Net income (loss) per common share, basic and diluted
Net income (loss) per common share from continuing operations, basic	$ 0.04	$ 0
Net income (loss) per common share from continuing operations, diluted	0.04	0
Net income (loss) per common share from discontinued operations, basic	0	0
Net income (loss) per common share from discontinued operations, basic	$ 0	$ 0
Weighted average shares outstanding - basic	413,136	401,964
Weighted average shares outstanding - diluted	426,586	424,065
Medical Services Revenue
Revenues:
Total revenues	$ 1,134,830	$ 652,423
Other Operating Revenue
Revenues:
Total revenues	$ 1,317	$ 1,022